Search Count: 16
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-((4-Cyclopropyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)Benzaldehyde (Compound 5B)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY9, ACT |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY9, ACT
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-Hexyl-2-Hydroxyphenoxy)Benzaldehyde (Compound 5A) - Spacegroup C2
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY8, DMS, GOL |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY8, DMS, GOL
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-Hexyl-2-Hydroxyphenoxy)Benzaldehyde (Compound 5A) - Spacegroup P41212
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, DMS, A1JY8 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, DMS, A1JY8
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-((4-Cyclopropyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)-3-Fluorobenzaldehyde (Compound 5C)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JZB |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JZB
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-Hexyl-2-Hydroxyphenoxy)Benzylidene)Hydrazine-1-Carbothioamide (Compound 6A)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY7, DMS, ACT |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY7, DMS, ACT
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-((4-Cyclopropyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)Benzylidene)Hydrazine-1-Carbothioamide (Compound 6B)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JZA, PIN |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JZA, PIN
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-((4-Cyclopropyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)-3-Fluorobenzylidene)Hydrazine-1-Carbothioamide (Compound 6C)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JZC |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JZC
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-((4-Cyclopropyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)-3-Chlorobenzylidene)Hydrazine-1-Carbothioamide (Compound 6D)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY6, PIN |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY6, PIN
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-((4-Butyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)Benzylidene)Hydrazine-1-Carbothioamide (Compound 6E)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY4, CL, NA |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY4, CL, NA
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With (E)-2-(4-(4-((4-Butyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)-3-Fluorobenzylidene)Hydrazine-1-Carbothioamide (Compound 6F)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JY5, PEG, NA |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JY5, PEG, NA
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-((4-Butyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)Benzaldehyde (Compound 5E)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JZT, NA |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JZT, NA
![]() |
Structure Of Inha From Mycobacterium Tuberculosis In Complex With 4-(4-((4-Butyl-1H-1,2,3-Triazol-1-Yl)Methyl)-2-Hydroxyphenoxy)-3-Fluorobenzaldehyde (Compound 5F)
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2026-07-15 Classification: OXIDOREDUCTASE Ligands: NAD, A1JZS, ACT |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION
Release Date: 2026-07-15
Ligands: NAD, A1JZS, ACT
![]() |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm557
Organism: Plasmodium falciparum (isolate 3d7)
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2020-04-22 Classification: OXIDOREDUCTASE Ligands: RL7, FMN, ORO |
Organism: Plasmodium falciparum (isolate 3d7)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-22
Ligands: RL7, FMN, ORO
![]() |
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm483
Organism: Plasmodium falciparum (isolate 3d7)
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2020-04-22 Classification: OXIDOREDUCTASE Ligands: RLA, FMN, ORO |
Organism: Plasmodium falciparum (isolate 3d7)
Method: X-RAY DIFFRACTION
Release Date: 2020-04-22
Ligands: RLA, FMN, ORO
![]() |
Crystal Structure Of M. Tuberculosis Kasa In Complex With N-(1H-Indazol-5-Yl)Butane-1-Sulfonamide
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2020-04-08 Classification: TRANSFERASE Ligands: EDO, O6Z, NA, PG4 |
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION
Release Date: 2020-04-08
Ligands: EDO, O6Z, NA, PG4
![]() |
Crystal Structure Of M. Tuberculosis Kasa In Complex With 4,4,4-Trifluoro-N-(Isoquinolin-6-Yl)Butane-1-Sulfonamide
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION Resolution:2.89 Å Release Date: 2020-04-08 Classification: TRANSFERASE Ligands: PG4, NA, O6W |
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION
Release Date: 2020-04-08
Ligands: PG4, NA, O6W
